Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 20, 2026
Novo Nordisk introduces "There's Only One Ozempic®" campaign, reuniting Justin Long and John Hodgman
View original at finance.yahoo.comNovo Nordisk introduces "There's Only One Ozempic®" campaign, reuniting Justin Long and John Hodgman Campaign aims to meet adults living with type 2 diabetes where they are, using educational messages, levity, and lively banter to spotlight Ozempic®'s FDA-approved uses Campaign focuses specifically on what makes the ic…
Lo que extrajimos de esta fuente
The claims Via News extracted from this document. We point to the source; we don't replace it.
Ozempic has the most FDA-approved uses among GLP-1s for type 2 diabetes
80% confidenceOzempic is the only FDA-approved GLP-1 that improves blood sugar along with diet and exercise and reduces the risk of major cardiovascular events and worsening kidney disease
80% confidenceNot all GLP-1s are the same, and people with type 2 diabetes should talk with their doctors about whether Ozempic is right for them
80% confidenceIt's important for people to learn more about their medication options and have that discussion with their doctors
80% confidenceHumor has a way of opening the door to conversations people might otherwise avoid
80% confidenceOnly Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic
80% confidence
Data points we hold from this source
| Novo Nordisk A/S · manufacturing locations | 12 facilities |
| Novo Nordisk A/S · us presence duration | 40 years |
| Novo Nordisk A/S · state presence | 8 states |